Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSC Transplant for Dyskeratosis Congenita and Severe Aplastic Anemia
NCT00455312Phase 3Completed
- Sponsor
- Masonic Cancer Center
- Start
- Aug 2007
- Primary completion
- Mar 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of hematopoietic stem cells in dyskeratosis congenita (DC), aplastic anemia, sponsored by Masonic Cancer Center. Started Aug 2007; status: completed.
02
Drugs
hematopoietic stem cells
03
Conditions
dyskeratosis congenita (DC)aplastic anemia
Beyond the preview
Go deeper on NCT00455312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455312.